Prana Biotechnology (PRAN)
Prana Biotechnology Total Interest Expense (Quarterly)
View 4,000+ financial data types
Prana Biotechnology Total Interest Expense (Quarterly) Chart
Prana Biotechnology Historical Total Interest Expense (Quarterly) Data
Export Data Date Range:| Data for this Date Range |
|---|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
PRAN Total Interest Expense (Quarterly) Benchmarks
| Companies | |
|---|---|
| Halozyme Therapeutics | 0.6629M |
| Celgene | 22.70M |
| Kindred Biosciences |
PRAN News
Business Wire 04/23 09:01 ET
Street Insider 04/10 14:52 ET
